Technology
Performance And Safety Of A Multi-Cancer Early Detection Test: The Pathfinder 2 Study
By Nature
Population
PATHFINDER 2 was a prospective, interventional study of an MCED test in participants aged 50 years or older without clinical suspicion of cancer who had not been diagnosed with or treated for cancer within 3 years prior to enrollment. A to ...Read more